Floatz logo

1 asset in Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell-Negative, NK Cell-Negative, Due To Adenosine Deaminase Deficiency

Therapeutic assets addressing Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-Negative, B Cell-Negative, NK Cell-Negative, Due To Adenosine Deaminase Deficiency, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
No assets available.